Eyelash Hypotrichosis / Inadequate Eyelash Growth Treatment
Covered by Aetna in California

Generic bimatoprost ophthalmic solution 0.03% — apply one drop to a sterile applicator (included) and apply nightly to the upper eyelid margin (base of lashes) only; do not apply to lower lid; results visible at 8–12 weeks, full effect at 16 weeks; continued nightly application required to maintain results

Latisse branded (same active ingredient as generic bimatoprost 0.03% — applicators included; some patients prefer the packaging convenience); off-label prostaglandin analogs (e.g., travoprost, latanoprost, as eyelash growth agents — not FDA-approved for this indication, cheaper generics available around $15–$30); peptide-based serums (OTC, no FDA approval, variable evidence): these are cosmetic alternatives that do not require a prescription; eyelash extensions (immediate cosmetic effect, but risk of allergic contact dermatitis from adhesives and mechanical lash trauma)

No — not covered by Aetna CA or any standard commercial insurer for cosmetic use. Self-pay cost: generic bimatoprost 0.03% ophthalmic solution (3 mL, a 4-month supply) typically $30–$60 at California pharmacies. TDMD visit: $49. Total for first visit + medication: approximately $80–$110.

Bimatoprost 0.03% (Latisse) is FDA-approved since 2008 for eyelash hypotrichosis — it prolongs the anagen (active growth) phase of the eyelash hair cycle via prostaglandin F2α receptor agonism. Clinical trials show approximately 25% increase in eyelash length and 106% increase in fullness after 16 weeks. Results are not permanent — lashes return to baseline within several weeks of stopping. Known side effects: conjunctival hyperemia (up to 45% — mild redness), eyelid skin darkening (reversible), iris pigmentation change (rare but potentially permanent — patients with light-colored irides should be counseled). Bimatoprost should not be applied to the lower eyelid margin or allowed to drip into the eye, as intraocular entry is a theoretical risk for IOP reduction effects.

FDA approval determines whether a drug is legal to prescribe — it does not obligate insurance coverage. Aetna CA's benefit design explicitly excludes elective cosmetic treatments, and eyelash growth for cosmetic purposes falls into this category. The FDA-approved indication (hypotrichosis) covers both cosmetic and medically caused lash loss, but insurers draw the line at cosmetic use. The only realistic path to coverage would be documented medical-condition-caused lash loss (e.g., chemotherapy alopecia, severe alopecia areata affecting eyelashes) with prior authorization — even then approval is not guaranteed and varies by plan.

Yes — generic bimatoprost ophthalmic solution 0.03% contains the identical active ingredient and concentration as Latisse. The only differences are packaging (generic does not include the single-use applicators that come with Latisse) and price. Generic bimatoprost is available at CVS, Walgreens, Rite Aid, Costco, and most independent pharmacies in California for $30–$60 for a 3 mL bottle (typically a 4-month supply). If applicators are preferred, single-use cosmetic eyeliner brushes can be used instead. Dr. Bhavsar will send the prescription to your preferred California pharmacy.

Iris pigmentation darkening with prostaglandin analogs like bimatoprost is a real but rare side effect seen primarily when the drug is used as eye drops for glaucoma (enters the anterior chamber). With the eyelash application protocol — applying only to the upper lid skin margin with an applicator and wiping away excess — intraocular exposure is minimal, and iris pigmentation change has not been reported as a clinically significant issue in cosmetic Latisse trials. The eyelid skin darkening (periorbital hyperpigmentation) is more common, affects darker skin tones more, and is reversible upon stopping. Dr. Bhavsar will review your risk profile during the video visit.

Yes. Aetna commercial plans cover telehealth visits for Eyelash Hypotrichosis / Inadequate Eyelash Growth in California. TeleDirectMD (Dr. Parth Bhavsar, MD, NPI: 1104323203) is an in-network telehealth provider with Aetna in California. Your standard Aetna telehealth copay applies — typically $10–$40 for most commercial plans. If clinically appropriate, your prescription is sent to your California pharmacy immediately after your visit.

Most Aetna commercial plans in California have telehealth copays of $10–$40. Often $0–$20 for employer plans. Your exact cost depends on your specific plan and whether your deductible has been met. Log into your Aetna member portal or call the member services number on your card to verify your telehealth copay before your eyelash growth treatment visit. Self-pay is always available for a flat $49 if you prefer to skip insurance.

If your specific Aetna plan is not in-network with TeleDirectMD in California, or if your deductible has not yet been met, you can book as a self-pay patient for a flat $49 fee — same physician, same quality of care, no insurance needed. You may also be eligible to submit an out-of-network claim to Aetna for partial reimbursement depending on your plan's out-of-network benefit.

TeleDirectMD typically offers same-day and next-day video visits. Book at teledirectmd.com/book-online and select a time that works for you. Most patients are seen within a few hours of booking during business hours. Your eyelash growth treatment symptoms are evaluated by Dr. Bhavsar, MD — not a nurse practitioner or PA — ensuring you receive a board-certified clinical assessment.

Yes. TeleDirectMD is operated by Dr. Parth Bhavsar, MD (NPI: 1104323203), a board-certified Family Medicine physician. TeleDirectMD is LegitScript certified, HIPAA compliant, and is contracted as an in-network telehealth provider with Aetna in California. Claims are billed using standard CPT codes (99213/99214) and submitted electronically to Aetna.

Yes. Telehealth visits with a licensed physician are qualified medical expenses eligible for FSA (Flexible Spending Account) and HSA (Health Savings Account) payment. If your Aetna plan applies your deductible first, your FSA or HSA card can be used to pay your portion. The $49 self-pay option is also FSA/HSA eligible.